All Stories

  1. Cassia siamea Role in Diabetes Management: Insights from In vitro and In silico Investigations on α-Glucosidase and α-Amylase Inhibition
  2. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents
  3. Controlled degradation and kinetics response in calcium silicate doped with sodium alginate/functionalized multi-walled carbon nanotube composite 3D scaffolds for cartilage regeneration
  4. Exosomes: current knowledge and future perspectives
  5. Discovery of novel PARP-1 inhibitors using tandem in silico studies: integrated docking, e-pharmacophore, deep learning based de novo and molecular dynamics simulation approach
  6. Identification of behenic acid as medicinal food for the diabetes mellitus: structure-based computational approach and molecular dynamics simulation studies
  7. Identification of Mpro inhibitors of SARS-CoV-2 using structure based computational drug repurposing
  8. In Silico Identification of Antifungal Compounds as Mutant DHFRase Inhibitors: Structure-Based Approach, Molecular Dynamics Simulation and Structural Integrity Analysis
  9. Structure based virtual screening of natural compounds and molecular dynamics simulation: Butirosin as Dipeptidyl peptidase (DPP-IV) inhibitor
  10. Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: Structure based virtual screening, molecular dynamics simulation and knowledge based SAR studies
  11. Computational screening of Natural compounds as anti diabetic agent
  12. Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors –α/γ dual agonists for treatment of metabolic disorders
  13. Identification of novel G-protein coupled receptor 40 (GPR40) agonists by hybrid in silico screening techniques and molecular dynamics simulations thereof
  14. Norbixin, an apocarotenoid derivative activates PPARγ in cardiometabolic syndrome: Validation by in silico and in vivo experimental assessment
  15. Deciphering PPARγ activation in cardiometabolic syndrome: studies by in silico and in vivo experimental assessment